Cancer

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Third known case of HIV remission after stem cell transplant

After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months

Reducing medical costs for inpatients with thyroid cancer

Professor Hiroki Konno at Nihon University explores proposals for reducing treatment costs for patients with thyroid cancer in Japan.

New potential therapy for aggressive bladder cancer

Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)

Mutually supportive relationships improve future health

Good, social relationships mean an individual receives but also gives significant support - now, scientists suggest that the giving part may improve future health.

AI & cancer: Big data, big gains for medicine

Orlando Agrippa, CEO and Founder of RwHealth, turns the spotlight on AI and cancer, where big data brings big gains for medicine

Single cell cancer research

Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.

Non-melanoma skin cancer

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.

Drug for ovarian cancer shows 52% reduction in death

Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.

Scientists discover new treatment to fight pancreatic cancer

The potential pancreatic cancer treatment combines an ultrasound and immunotherapy method, with substantial "anti-cancer" benefits in lab mice.

Prospects for minimally invasive and optimally effective cancer immunotherapy

Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.

Drug gives 34% protection against lung cancer recurrence

The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.

Has COVID-19 impacted physicians who care for children with cancer?

Research reveals a global link between COVID-19 and the capacity of paediatric oncology health professionals to provide high quality care.

New blood test identifies metastatic status of cancer

A new minimally invasive and inexpensive blood test can detect a range of cancers in patients with non-specific symptoms, and can indicate whether the cancer has spread.

Getting personal in brain tumour therapy: Matching therapies to patients

Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field

A PinPoint solution to harnessing the power of AI in cancer diagnostics

PinPoint Data Science addresses the acute challenges of cancer diagnostics in the post-COVID NHS. Could their innovative machine learning platform be the low-cost, high-impact solution UK healthcare needs?

Contemporary immunology and its relationship to medicine

Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders